Pediatric drug information available at the time of new drug approvals: A cross-sectional analysis-Reference-Cited by-同舟云学术

Pediatric drug information available at the time of new drug approvals: A cross-sectional analysis

Published:2017-11-17 Issue:2 Volume:27 Page:161-167
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Hudgins Joel D.¹²³^ORCID,Bacho Matthew A.⁴,Olsen Karen L.²⁵,Bourgeois Florence T.¹²³⁵

Affiliation:

1. Division of Emergency Medicine; Boston Children's Hospital; Boston MA USA

2. Department of Pediatrics; Harvard Medical School; Boston MA USA

3. Department of Emergency Medicine; Harvard Medical School; Boston MA USA

4. Division of Pediatric and Maternal Health, Office of New Drugs, Center for Drug Evaluation and Research; US Food and Drug Administration; Silver Spring MD USA

5. Computational Health Informatics Program; Boston Children's Hospital; Boston MA USA

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.4351/fullpdf

Reference23 articles.

1. An update on the therapeutic orphan;Wilson;Pediatrics,1999

2. A literature review on off-label drug use in children;Pandolfini;Eur J Pediatr,2005

3. Patterns of off-label prescribing in the pediatric intensive care unit and prioritizing future research;Czaja;J Pediatr Pharmacol Ther,2015

4. Off-label drug use in hospitalized children;Shah;Arch Pediatr Adolesc Med,2007

5. Pediatric information in drug product labeling;Sachs;JAMA,2012

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023;International Journal of Pharmaceutics: X;2024-06

2. Development and Evaluation of a Prototype Mobile Application for Intravenous Drug Dose Calculation in Overweight and Obese Thai Children: Precision Dosing in Practice;Hospital Pharmacy;2024-02-07

3. Root cause analysis of medication errors of the most frequently involved active substances in paediatric patients;Research in Social and Administrative Pharmacy;2024-02

4. Timing for First-in-Minor Clinical Trials of New Cancer Drugs;The Journal of Pediatrics;2023-12

5. Extrapolation of midazolam disposition in neonates using physiological based pharmacokinetic/pharmacodynamic (PBPK/PD) modelling;2023-11-30